p27KIP1 and GATA-1 are potential downstream molecules in activin A-induced differentiation and apoptosis pathways in CML cells

Oncology Reports

Volumn 16, Issue 5, 2006, Pages 1099-1103

  Fukuchi, Yumi ^a,b   Yamato, Kenji ^c   Kawamura, Chiharu ^a   Ikeda, Yasuo ^a   Kizaki, Masahiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Activin A; Apoptosis; Differentiation; GATA 1

Indexed keywords

ACTIVIN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; TRANSCRIPTION FACTOR GATA 1;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CHRONIC MYELOID LEUKEMIA; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ACTIVINS; APOPTOSIS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GATA1 TRANSCRIPTION FACTOR; HUMANS; LEUKEMIA, MYELOID, CHRONIC;

EID: 34547489197     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.5.1099     Document Type: Article

References (40)

1. Chellapan SP, Giordano A and Fisher PB: Roles of cyclin-dependent kinase inhibitors: lessons from knockout mice. Curr Top Microbiol Immunol 227: 57-103, 1998.
2. Massague J: The transforming growth factor-β family. Annu Rev Biochem 67: 753-791, 1998.
3. Reynisdottir I, Polyak K, Iavarone A, et al: Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9: 1831-1845, 1995.
4. Massague J, Attisano L and Wrana J: The TGF-β family and its composite receptors. Trends Cell Biol 4: 172-178, 1994.
5. Liu M, Lee MH, Cohen M, Bommakanti M and Freedman LP: Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10: 142-153, 1996. (Pubitemid 26049905)
6. Muto A, Kizaki M, Yamato K, et al: 1,25-dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line UF-1 associated with expression of p21WAF1/CIP1 and p27KIP1. Blood 93: 2225-2233, 1999. (Pubitemid 29153624)
7. WAF1/ CIP1by transforming growth factor-β. J Bio Chem 274: 35381-35387, 1999.
8. WAF1/CIP1regulation by transforming growth factor-β. J Bio Chem 275: 29244-29256, 2000.
9. Macleod KF, Sherry N, Hannon G, et al: p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9: 935-944, 1995.
10. CIP1in muscle and other terminally differentiating cells. Science 267: 1024-1027, 1995.
11. WAF1/ CIP1/SDI1in differentiating human leukemic cells. J Clin Invest 95: 973-979, 1995.
12. CIP1/WAF1induction by fibroblast growth factor-2, platelet-derived growth factor, and transforming growth factor-β1. Cell Growth Differ 10: 621-628, 1999.
13. Katayose Y, Kim M, Rakker AN, Li Z, Cowan KH and Seth P: Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res 57: 5441-5445, 1997. (Pubitemid 28006743)
14. kip1in ceramide-mediated apoptosis in HL-60 cells. Cancer Lett 151: 39-48, 2000.
15. KIP1. J Cell Biochem 80: 339-345, 2001.
16. KIP1in neuronal differentiation of embryonal carcinoma cells. Mol Brain Res 77: 209-221, 2000.
17. de Koning JP, Soede-Bobok AA, Ward AC, et al : STAT3-mediated differentiation and survival of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27KIP1. Oncogene 19: 3290-3298, 2000. (Pubitemid 30487415)
18. Tamir A, Petrocelli T, Steler K, et al: Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest. Cell Growth Differ 11: 269-277, 2000. (Pubitemid 30347207)
19. KIP1and inactivation of cdk2 kinase. Blood 96: 2746-2754, 2000.
20. KIP1coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 11: 492-503, 1997.
21. Pierelli L, Marone M, Bonanno G, et al: Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-β1 is a cell cycle-independent effect and influences their hematopoietic potential. Blood 95: 3001-3009, 2000.
22. Ito E, Iwahashi Y, Yanagisawa Y, Suzuki Y, Sugano S, Yuasa Y and Maruyama K: Two short sequences have positive effects on the human p27KIP1gene transcription. Gene 228: 93-100, 1999. (Pubitemid 29136690)
23. Fukuchi Y, Kizaki M, Yamato K, et al : Mcl-1, an earlyinduction molecule, modulates activin A-induced apoptosis and differentiation of CML cells. Oncogene 20: 704-713, 2001. (Pubitemid 32179339)
24. Tamir A, Howard J, Higgins RR, et al : Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol 19: 4452-4464, 1999. (Pubitemid 29242019)
25. Calligaris R, Bottardi S, Cogoi S, Apezteguia I and Santoro C: Alternative translation initiation site usage results in two functionally distinct forms of the GATA-1 transcription factor. Proc Natl Acad Sci USA 92: 11598-11602, 1995. (Pubitemid 26014161)
26. De Maria R, Zeuner A, Eramo A, et al: Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401: 489-493, 1999.
27. KIP1. J Biol Chem 12: 2686-2692, 2000.
28. Rosson D and O'Brien T: AP-1 activity affects the levels of induced erythroid and megakaryocytic differentiation of K562 cells. Arch Biochem Biophys 352: 298-305, 1998. (Pubitemid 28368598)
29. Shelly C, Petruzzelli L and Herrera R: PMA-induced phenotypic change in K562 cells: MAPK-dependent and -independent events. Leukemia 12: 1951-1961, 1998. (Pubitemid 28554468)
30. Shen X, Hu PP, Liberati NT, Datto MB, Frederick JP and Wang XF: TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell 9: 3309-3319, 1998. (Pubitemid 28551031)
31. Gregoli PA and Bondurant MC: Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors. J Cell Physiol 178: 133-143, 1999. (Pubitemid 29034856)
32. Zermati Y, Garrido C, Amsellem S, et al: Caspase activation is required for terminal erythroid differentiation. J Exp Med 193: 247-254, 2001. (Pubitemid 32524456)
33. Gregory T, Yu C, Ma A, Orkin SH, Blobel GA and Weiss MJ: GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 94: 87-96, 1999. (Pubitemid 29300137)
34. Kapur R and Zhang L: A novel mechanism of cooperation between c-kit and erythropoietin receptor. J Bio Chem 276: 1099-1106, 2001.
35. Zermati Y, Fichelson S, Valensi F, et al: Transforming growth factor inhibits erythropoietin by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol 28: 885-894, 2000.
36. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S and Akhurst RJ: Defective hematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 121: 1845-1854, 1995.
37. Shiozaki M, Kosaka M and Eto Y: Activin A: A commitoment factor in erythroid differentiation. Biochem Biophys Res Commun 242: 631-635, 1998.
38. Liu F, Shao LE and Yu J: Truncated activin type II receptor inhibits erythroid differentiation in K562 cells. J Cell Biochem 78: 24-33, 2000. (Pubitemid 30346380)
39. Huber TL, Zhou Y, Mead PE and Zon LI: Cooperative effects of growth factors involved in the induction of hematopoietic mesoderm. Blood 92: 4128-4137, 1998. (Pubitemid 28544329)
40. Seshasayee D, Gaines P and Wojchowski DM: GATA-1 dominantly activates a program of erythroid gene expression in factor-dependent myeloid FDCW2 cells. Mol Cell Biol 18: 3278-3288, 1998. (Pubitemid 28240500)